Jorna Therapeutics

Jorna Therapeutics is leveraging novel RNA editing with AI-designed tools to redefine medicine. Founded by scientists from the Broad Institute and Harvard, Jorna is using cutting-edge synthetic biology, machine learning and genome/metagenome mining to treat genetic and degenerative diseases. The vision is to build the next generation tools for editing genomes and transcriptomes that have wide applicability for various diseases.

Jobs: